Vittoria Lopez

Sulfated Polysaccharides from Macroalgae Are Potent Dual Inhibitors of Human ATP-Hydrolyzing Ectonucleotidases NPP1 and CD39

C. Müller, J. Sévigny, J. Pelletier, 2021, Marine drugs.

Protein kinase inhibitor ceritinib blocks ectonucleotidase CD39 – a promising target for cancer immunotherapy

J. Sévigny, J. Pelletier, E. Tolosa, 2022, Journal for ImmunoTherapy of Cancer.

Recombinant expression of ecto-nucleotide pyrophosphatase/phosphodiesterase 4 (NPP4) and development of a luminescence-based assay to identify inhibitors.

C. Müller, H. Stephan, Sang-Yong Lee, 2020, Analytical biochemistry.

Targeting the Main Protease of SARS‐CoV‐2: From the Establishment of High Throughput Screening to the Design of Tailored Inhibitors

A. Schiedel, C. Müller, M. Gütschow, 2021, Angewandte Chemie.

Nucleotide Analog ARL67156 as a Lead Structure for the Development of CD39 and Dual CD39/CD73 Ectonucleotidase Inhibitors

C. Müller, J. Sévigny, J. Pelletier, 2020, Frontiers in Pharmacology.

Heparins are potent inhibitors of ectonucleotide pyrophosphatase/phospho-diesterase-1 (NPP1) – a promising target for the immunotherapy of cancer

J. Pelletier, G. Bendas, O. Vanakker, 2023, Frontiers in immunology.